Mesothelioma: Immunotherapy

(asked on 23rd June 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of trialling CAR T Cell Therapy for the treatment of Mesothelioma.


Answered by
Edward Argar Portrait
Edward Argar
Minister of State (Ministry of Justice)
This question was answered on 30th June 2021

The Department funds and supports research into health and care research through the National Institute for Health Research (NIHR). The NIHR is supporting the delivery of the study ‘Immunotherapy for malignant mesothelioma using ErbB re-targeted Chimeric Antigen Receptor (CAR) T-cells in combination with checkpoint inhibition’ funded by the Asthma UK and British Lung Foundation Partnership.

Reticulating Splines